1-1 of 1
generic substitution
Close
Sort by
Journal Articles

Realized and Projected Cost Savings from the Introduction of Generic Imatinib, with Minimal Additional Savings to Payers through Formulary Management

Lisa Bloudek, John Brokars, MS, Campbell David, PharmD, MS, Dinara Makenbaeva, MD MBA
Journal: Blood
Blood (2018) 132 (Supplement 1): 3533.
https://doi.org/10.1182/blood-2018-99-111966
Published: 2018